Tandem Diabetes Care, Inc.
TNDM
$22.37
-$0.48-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.06% | 15.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.06% | 15.85% | |||
| Cost of Revenue | -7.33% | 4.92% | |||
| Gross Profit | -24.80% | 26.31% | |||
| SG&A Expenses | -0.82% | 6.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.05% | 4.88% | |||
| Operating Income | -5,826.80% | 97.77% | |||
| Income Before Tax | -763,156.25% | 100.07% | |||
| Income Tax Expenses | 1,245.74% | -216.01% | |||
| Earnings from Continuing Operations | -17,392.19% | 103.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17,392.19% | 103.25% | |||
| EBIT | -5,826.80% | 97.77% | |||
| EBITDA | -924.00% | 116.74% | |||
| EPS Basic | -17,346.49% | 103.21% | |||
| Normalized Basic EPS | -1,859.69% | 108.85% | |||
| EPS Diluted | -17,346.49% | 103.21% | |||
| Normalized Diluted EPS | -1,868.95% | 108.81% | |||
| Average Basic Shares Outstanding | 0.71% | 0.61% | |||
| Average Diluted Shares Outstanding | 0.37% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||